Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences - June, 2006
63 articles
- Johnson & Johnson Sues To Stop Generic Risperdal
- Cephalon Takes Another Blow Over Provigil
- Senate Looks To Regulate Dietary Supplements
- Another Orthopedic Company Stung With Subpoena
- PhRMA Blasted Over Authorized Generics Study
- Mixed Ruling For J&J In Stent Dispute
- Metabolife Slims Down Ephedra Settlements
- Big Pharma Lashes Out At Generic Competition
- Novartis, Mylan Spar Over Breast Cancer Treatment
- Pfizer Remains Immune To Lipitor Attack In U.K.
- Riled By Schering-Plough Case, Senators Introduce Bill
- Impotence Drug Price-Fixing Investigated
- FDA Soft On Enforcement, Report Charges
- Medical Device Maker Sues Rival Over Screw Patent
- Teva Halts Biaxin Generic Despite Court OK
- Supreme Court Passes On Schering-Plough Appeal
- Supreme Court Set To Review Obviousness
- DOJ Subpoenas Orthopedic Companies
- Plavix Settlement Updated To Appease FTC
- Cos. Accused of Blowing Up Balloon Catheter Market
- Bayer Throws In Towel In Viral Patent Dispute
- Case Against Generic Paxil Sputters In Appeals Court
- Teva's Generic Zocor Exclusivity Upheld
- Court Docs Unveil More Bad News For Guidant
- LabCorp Shelved, But Legal Issues Linger, Say Experts
- Patent Suit Over Dermatology Drug Dismissed
- Another Trial Set To Begin In Vioxx Fallout
- "Inequitable Conduct" Ruling Ends Patent Battle
- Federal Circuit Gives Teva Go-Ahead For Generic Biaxin
- Zocor Offer Draws Predatory Pricing Accusations
- Rothwell Figg Gains Expertise With Two New Attorneys
- Court Tosses Securities Fraud Charges Against ICN
- Darby & Darby Opens German Office
- Court Mulls Foreign Patents In Inventor's Case Vs. Cordis
- Generic Paxil Is Legal, Supreme Court Rules
- Chinese Drug Makers Appeal Pfizer's Viagra Win
- "Dog Ate My Homework" Bill Stirs Controversy
- Law Firm Profile: Kaye Scholer LLP
- Ruling Against Johnson & Johnson Unit Affirmed
- Judge Approves Settlement Over Hospital Bed Discounts
- Microsoft, Intel Riffs Shape Article 82 Debate
- EPO Knocks Down Trio of Geron Patent Claims
- Seven More Companies Queried In Backdating Probe
- Aphton To Auction Off Assets
- Barr Settles With Sandoz For $22.5M Over Blood Thinner
- Becton Dickinson Poked By Syringe Antitrust Suit
- Judge Throws Out Suit Against Cell Therapeutics
- Deal In Works For Troubled Biopharmaceutical Company
- ITC To Investigate Sanofi Over Insulin Delivery Patent
- D.C. Circuit Upholds FDA Rule On 180-Day Exclusivity
- Amgen To Pay Hospital $186M Over Royalties
- Merck Hits Barr With Suit Over Generic Fosamax
- Pfizer's Viagra Patent Should Stand Firm: China Court
- In Acular Patent Feud, Apotex Suffers Blow
- D.C. Snapshot: Cleary Gottlieb Steen & Hamilton LLP
- Palomar Wins $22M Settlement In Patent Suit
- Judge Allows Drug Battle Over TriCor To Proceed
- AstraZeneca Sues Generic Drug Maker Over Prilosec
- Lawsuit Launched To Clear Up Skin Care Dispute
- Poché Moves To Cooley Godward
- Embattled Metabolife Nears Ephedra Settlements
- D.C. Snapshot: Weil Gotshal & Manges LLP
- E.U. Closes In On Pediatric Drug Patent Extensions